Holen Sie sich die Stockscreener-App
25.65
6.38%
1.47
Schlusskurs vom Vortag:
$24.18
Offen:
$24.4
24-Stunden-Volumen:
42,708
Relative Volume:
0.34
Marktkapitalisierung:
$321.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.48M
KGV:
-24.66
EPS:
-1.04
Netto-Cashflow:
$-28.71M
1W Leistung:
+8.95%
1M Leistung:
+28.03%
6M Leistung:
+106.11%
1J Leistung:
+32.31%
1-Tages-Spanne:
$24.04
$25.95
1-Wochen-Bereich:
$21.86
$27.50
52-Wochen-Spanne:
$4.90
$31.27
Forte Biosciences Inc Stock (FBRX) Company Profile
Firmenname
Forte Biosciences Inc
Sektor
Branche
Telefon
(310) 618-6994
Adresse
3060 PEGASUS PARK DRIVE, DALLAS, CA
Vergleichen Sie FBRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
25.66 | 302.90M | 0 | -31.48M | -28.71M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.17 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.41 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
407.74 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
812.45 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.73 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-25 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-18 | Eingeleitet | Guggenheim | Buy |
| 2025-01-21 | Eingeleitet | TD Cowen | Buy |
| 2024-04-08 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | Hochstufung | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | Herabstufung | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | Herabstufung | Truist | Buy → Hold |
| 2021-05-14 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-26 | Eingeleitet | Citigroup | Buy |
| 2020-08-28 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | Eingeleitet | Truist | Buy |
Alle ansehen
Forte Biosciences Inc Aktie (FBRX) Neueste Nachrichten
Will Forte Biosciences Inc. stock reach all time highs in 2025CPI Data & Expert Curated Trade Setups - ulpravda.ru
What margin trends mean for VNET Group Inc. Depositary Receipt stockTrade Risk Report & Long-Term Safe Investment Ideas - ulpravda.ru
What valuation multiples suggest for HAYW stockWeekly Risk Summary & Consistent Growth Equity Picks - ulpravda.ru
ulpravda ru > 2026> What insider trading reveals about COLL stockChart Signals & Low Drawdown Momentum Ideas - ulpravda.ru
Will Quad Graphics Inc. stock return to pre crisis levels2025 Key Highlights & Expert Approved Trade Ideas - ulpravda.ru
Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - Defense World
(FBRX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Will Avax Apparels and Ornaments Limited Bounce From 52 Week LowPortfolio Risk Assessment & Interactive Learning for Better Returns - earlytimes.in
Will Sahasra Electronic Solutions Limited Recover After Recent DeclineSupport and Resistance Levels & Access Free Risk Analysis Before You Invest - earlytimes.in
What drives Forte Biosciences Inc stock priceMean Reversion Trades & Receive Monthly Expert Trading Blueprints - earlytimes.in
Chief Financial Officer of Forte Biosciences Picks Up 30% More Stock - Yahoo Finance
Institutional investors may adopt severe steps after Forte Biosciences, Inc.'s (NASDAQ:FBRX) latest 15% drop adds to a year losses - simplywall.st
Insider Buying: Antony Riley Acquires Shares of Forte Biosciences Inc (FBRX) - GuruFocus
Trading Bots Trigger Alerts on Shri Venkatesh Refineries Limited ActivityHigh Frequency Trading Trends & Fast Profit Trading Ideas - bollywoodhelpline.com
Indo Tech Transformers Limited (INDOTECH) Stock RalliesStock Liquidity Analysis & Discover Stocks Experts Are Watching - bollywoodhelpline.com
Dr. Lal PathLabs Limited (LALPATHLAB) Expands into New MarketRisk-Reward Ratio Analysis & Fast Profit Capital Growth - bollywoodhelpline.com
Forte Biosciences Inc. (FBRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Shorts Report: Will Forte Biosciences Inc stock return to pre crisis levelsJuly 2025 Update & Consistent Profit Trade Alerts - moha.gov.vn
(FBRX) Volatility Zones as Tactical Triggers - Stock Traders Daily
Gaining experience for doing equity researchDividend Yield Trends & Free Fastest Return On Investment - bollywoodhelpline.com
Rate Hike: Is Forte Biosciences Inc stock dividend yield sustainable2025 Pullback Review & Weekly Watchlist of Top Performers - moha.gov.vn
Stock Traders Buy Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - Bluefield Daily Telegraph
New Forte Biosciences hire receives options for 75,000 shares - Stock Titan
Gainers Report: Can Cytosorbents Corporation stock deliver sustainable ROEJuly 2025 Patterns & Fast Exit and Entry Trade Guides - moha.gov.vn
Why analysts upgrade Forte Biosciences Inc. stock2025 Top Gainers & Expert Curated Trade Ideas - Улправда
Ester Industries Limited Recovers — But Is It SustainableGap Fill Strategies & Low Risk Capital Growth - Bollywood Helpline
Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Dow Update: Why Dune Acquisition Corporation Equity Warrant stock remains on buy listsPortfolio Profit Report & Low Risk Entry Point Guides - Улправда
Will Forte Biosciences Inc. stock outperform international peersTrade Risk Report & AI Enhanced Execution Alerts - DonanımHaber
Forte Biosciences initiated with an Outperform at Evercore ISI - MSN
Is Forte Biosciences Positioned For More Gains Ahead Of 2026 Clinical Readouts? - RTTNews
Swing Trade: Will Forte Biosciences Inc 37T stock outperform value peers2025 Retail Activity & Growth Focused Investment Plans - moha.gov.vn
Forte Biosciences Earnings Notes - Trefis
Positive week for Forte Biosciences, Inc. (NASDAQ:FBRX) institutional investors who lost 1.7% over the past year - Yahoo Finance
Federated Hermes Inc. Buys New Shares in Forte Biosciences, Inc. $FBRX - MarketBeat
Stock Traders Purchase High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - The Manila Times
Forte Biosciences (FBRX) Stock Analysis Report | Financials & Insights - Benzinga
What downside risks could hit Forte Biosciences Inc. (37T) stockJuly 2025 Weekly Recap & Technical Pattern Based Buy Signals - Newser
Recent Research Analysts’ Ratings Changes for Forte Biosciences (FBRX) - Defense World
What analyst consensus implies for Forte Biosciences Inc. (37T) stockWatch List & Trade Opportunity Analysis Reports - Newser
Is Forte Biosciences Inc. stock a top pick in earnings seasonJuly 2025 Update & Trade Opportunity Analysis - Newser
How forex fluctuations impact Forte Biosciences Inc. (37T) stockTrade Ideas & Weekly Hot Stock Watchlists - Newser
Is Forte Biosciences Inc. stock attractive for passive investors2025 Market WrapUp & High Accuracy Trade Signal Alerts - Newser
18,856 Shares in Forte Biosciences, Inc. $FBRX Purchased by Envestnet Asset Management Inc. - MarketBeat
Forte Biosciences, Inc. (FBRX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Forte Biosciences (NASDAQ:FBRX) Coverage Initiated by Analysts at Evercore ISI - MarketBeat
Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Forte Biosciences Inc-Aktie (FBRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jan 01 '26 |
Option Exercise |
0.00 |
375 |
0 |
41,895 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Dec 30 '25 |
Buy |
26.33 |
9,680 |
254,833 |
41,520 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Oct 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,974 |
| Wagner Paul A. | SEE REMARKS |
Oct 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
82,190 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jul 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,733 |
| Wagner Paul A. | SEE REMARKS |
Jul 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
81,038 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Apr 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,372 |
| Wagner Paul A. | SEE REMARKS |
Apr 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
79,806 |
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):